Regulators are holding back the pharmaceutical industry’s ability to innovate, according to Girish Malhotra, president of EPCOT International, a Pepper Pike, OH-based consulting firm focusing on manufacturing and technology for pharmaceuticals, chemicals, coatings and allied industries. Malhotra makes the claim in the first part of CPhI‘s new annual report to be released at the start of CPhI Worldwide in Madrid, October 9-11, 2018.…
WuXi Biologics CEO Named ISPE Annual Meeting Keynoter
Dr. Chris Chen, chief executive officer of WuXi Biologics (Shanghai) Co., Ltd., has been confirmed as final keynote speaker for the 2018 Annual Meeting & Expo of the International Society for Pharmaceutical Engineering (ISPE) taking place in Philadelphia, November 4–7. WuXi Biologics, with more than 2,800 employees, is an open-access integrated monoclonal antibodies discovery, development, and manufacturing platform serving global companies. In April the…
FDA Drug Shortages and Discontinuations: 8/22/18 Update
The FDA has issued recent updates on several drugs that are currently in shortage or have been discontinued: Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage) Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage) Calcium Gluconate Injection (Updated – Currently in Shortage) Cefotetan Disodium Injection (Updated – Currently in Shortage) Deferoxamine Mesylate for Injection, USP (Updated – Currently in Shortage)…
Anthem to Collaborate With Walmart on OTC Meds and Services
Middle East and Africa Pharma Economy Expected to Near $39B by 2021
Favorable market conditions are driving increased growth across the Middle East and North Africa pharmaceutical market, according to a report by CPhI, which cited aging and gentrifying populations, increased healthcare spending, and a modernizing supply chain as transforming prospects in the region. CPhI, a pharmaceutical event organizer, will be holding Middle East and Africa sessions September 3-5 in Abu Dhabi, United…
Direct-to-Consumer Asthma and COPD Solution Launched in U.S.
Adherium, a digital health platform that focuses on improving medication adherence and patient outcomes, has launched the Hailie solution in the U.S., following its recent Food and Drug Administration (FDA) 510(k) over-the-counter clearance to enable sales direct to consumers. The Hailie solution is designed to help patients achieve better adherence by providing people who live with…
FDA Drug Shortages And Discontinuations: 8/10/18 Update
The FDA has issued recent updates on several drugs that are currently in shortage or have been discontinued: Aminocaproic Acid Injection, USP (Updated – Currently in Shortage) Aminophylline Injection, USP (Updated – Currently in Shortage) Atropine Sulfate Injection (Updated – Currently in Shortage) Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage) Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage) Calcium…
Pharmaceutical Recalls Down, Medical Device Recalls Up In 2Q
In the second quarter of 2018, pharmaceutical recalls dropped 27 percent to 77, which is lower than six of the last eight quarters, while recalled units dropped 95 percent to nearly 15.9 million, but in line with the recent average quarter (2013-2016), according to the latest U.S. Recall Index released August 8 by Stericycle Expert Solutions. The Recall Index covers recalls…
FDA Drug Shortages And Discontinuations: 8/3/18 Update
The FDA has issued recent updates on several drugs that are currently in shortage or have been discontinued: Aminophylline Injection, USP (New – Currently in Shortage) Atorvastatin Calcium Tablets (New – Discontinuation) Atropine Sulfate Injection (Updated – Currently in Shortage) Bumetanide Injection, USP (Updated – Currently in Shortage) Cefepime Injection (Updated – Currently in Shortage) Cefotetan Disodium Injection (Updated – Currently in Shortage) Diltiazem…
ObvioHealth Mobile App Aims To Transform Clinical Studies
Full-service CRO ObvioHealth has launched ClaimIt, a 100-percent online and mobile application for site-less clinical studies. The app removes costly physical site visits, allowing study participants to take part in healthcare research from their homes, improving convenience and compliance, while lowering drop-out rates. The company said that the application, targeting pharmaceutical, nutritional, observational, and other studies, also creates opportunities to leverage data captured from connected devices for clinical evaluation.…